Coronavirus Disease (COVID-19)
Drugs with Insufficient Data

Drugs with Insufficient Data

Note

The following drugs have insufficient or no data supporting efficacy in the treatment of patients with COVID-19

Nitazoxanide

Ivermectin

Lopinvavir/ritonavir

Favipravir

Colchicine

Hydroxychloroquine

Not recommended due to data that suggest no benefit